Suchergebnisse - "Fukazawa, Masanori"

PubPharm (19)

1

Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2020

von Kawai, T. | Sun, B. | Yoshino, H. | +13

2

Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist

Erschienen: 2020

von Kawai, T. | Sun, B. | Yoshino, H. | +13

3

Tofogliflozin Improves Insulin Resistance in Skeletal Muscle and Accelerates Lipolysis in Adipose Tissue in Male Mice

enthalten in: Endocrinology | 2016

von Obata, A. | Kubota, N. | Kubota, T. | +12

4

Pharmacological analysis of SGLT2 inhibitor (tofogliflozin) using in vivo glucose clamp and titration protocols in rats and cynomolgus monkeys

enthalten in: Nihon yakurigaku zasshi. Folia pharmacologica Japonica | 2016

von Fukazawa, M. | Nagata, T. | Suzuki, M. | +2

5

Inhibition of MEK1 Signaling Pathway in the Liver Ameliorates Insulin Resistance

enthalten in: Journal of diabetes research | 2016

von Ueyama, A. | Ban, N. | Fukazawa, M. | +13

6

Competitive inhibition of SGLT2 by tofogliflozin or phlorizin induces urinary glucose excretion through extending splay in cynomolgus monkeys

enthalten in: American journal of physiology. Renal physiology | 2014

von Nagata, T. | Suzuki, M. | Fukazawa, M. | +8

CommentIn: Am J Physiol Renal Physiol. 2014 Jul 15;307(2):F147-8. - PMID 24872320

7

Competitive inhibition of SGLT2 by tofogliflozin or phlorizin induces urinary glucose excretion through extending splay in cynomolgus monkeys

enthalten in: American journal of physiology / Renal physiology | 2014

von Nagata, T. | Suzuki, M. | Fukazawa, M. | +8

8

Sites of Inhibition by a Plant-Growth Regulator, 4'-Chloro-2'-({alpha}-hydroxybenzyl)-isonicotinanilide (Inabenfide), and its Related Compounds in the Biosynthesis of Gibberellins

enthalten in: Plant & cell physiology | 2013

von Miki, T. | Kamiya, Y. | Fukazawa, M. | +2

9

Selective SGLT2 inhibition by tofogliflozin reduces renal glucose reabsorption under hyperglycemic but not under hypo- or euglycemic conditions in rats

enthalten in: American journal of physiology. Endocrinology and metabolism | 2013

von Nagata, T. | Fukazawa, M. | Honda, K. | +10

10

Selective SGLT2 inhibition by tofogliflozin reduces renal glucose reabsorption under hyperglycemic but not under hypo- or euglycemic conditions in rats

enthalten in: American journal of physiology / Endocrinology and metabolism | 2013

von Nagata, T. | Fukazawa, M. | Honda, K. | +10